Muscle Pharm Corp (MSLP) 4.2800 $MSLP I Believe

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Muscle Pharm Corp (MSLP) 4.2800 $MSLP

I Believe MusclePharm Has Shown Signs Of Significant Mismanagement
Paulo Santos - at Seeking Alpha - Mon Apr 06, 7:43PM CDT


MusclePharm: It's All About The Cash
Matthew Finston - at Seeking Alpha - Mon Apr 06, 8:09AM CDT


MusclePharm Officially Enters Into the Energy Drink Category With Energy Sport(TM) and Energy Sport Zero(TM)
Marketwired - Thu Apr 02, 11:00AM CDT
MusclePharm Corporation (OTCQB: MSLP), a scientifically driven, performance-lifestyle sports nutrition company, is launching two new energy drinks, MusclePharm Energy Sport(TM) and Energy Sport Zero(TM) which will be available at convenience stores and select retailers.

Targeted Training Products and Nutritional Supplements Combine for Global Growth Opportunities & New Branding Initiatives
PR Newswire - Thu Mar 26, 7:35AM CDT
Nutrition and training have a heavy influence of global supplement & brand marketing in today's consumer industry, entering into a billion dollar net worth of global sales. Vitamin & nutritional supplements are expected to account for larger revenue share of the total market in 2020 with some predicting a value of over $50Billion within the next five years. Supplement Companies in focus today are Axxess Pharma, Inc. (OTC: AXXE), GNC Holdings, Inc. (NYSE: GNC), MusclePharm Corporation (OTC: MSLP), Vitamin Shoppe, Inc. (NYSE: VSI).
VSI: 40.55 (-0.01), WWE: 13.42 (-0.30), GNC: 47.51 (+0.72)

Penny Stocks Alerts for PositiveID, GT Advanced, Tanzanian Royalty Exploration, Sino Agro Food, Aoxing Pharmaceutical, and MusclePharm
PR Newswire - Mon Mar 23, 7:45AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: PositiveID (OTCMKTS: PSID), GT Advanced (OTCMKTS: GTATQ), Tanzanian Royalty Exploration (NYSEMKT: TRX), Sino Agro Food (OTCBB: SIAF), Aoxing Pharmaceutical (NYSEMKT: AXN), and MusclePharm (OTCMKTS: MSLP).
AXN: 1.79 (-0.01), TRX: 0.40 (+0.01)

FitLife Brands: Update For Preliminary 2014 Results
The Enterprising Value Investor - at Seeking Alpha - Thu Mar 19, 10:01AM CDT


Why I Panic Sold MusclePharm (And Why You Should Tread Carefully)
John Nicholson - at Seeking Alpha - Wed Mar 18, 3:02PM CDT


MusclePharm's (MSLP) CEO, Brad Pyatt on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Mar 17, 10:48AM CDT


MusclePharm collapses after disappointing Q4 results
Seeking Alpha - at Seeking Alpha - Tue Mar 17, 9:48AM CDT


MusclePharm Q4 revenues off 13%, net loss widens four-fold; only $1M cash on hand
Seeking Alpha - at Seeking Alpha - Mon Mar 16, 5:01PM CDT


MusclePharm Reports 2014 Fourth-Quarter and Full-Year Financial Results
Marketwired - Mon Mar 16, 3:45PM CDT
MusclePharm Corporation (OTCQB: MSLP), a scientifically driven, performance-lifestyle sports nutrition company, today announced financial results for the fourth quarter and full year ended December 31, 2014.

Billion Dollar Omega-3 Fish Oil Market Forecasted to Continue to Grow - Company Receives FDA Approval for High Potency Omega-3 Recovery Supplements
PR Newswire - Mon Mar 16, 7:40AM CDT
The global market for fish oil omega-3 is projected to grow from $1.1 billion in 2011 to $1.7 billion by 2018. Globally rising awareness about the importance of omega-3 fatty acids - of which fish oil is a primary source - for several purposes in the human body, is an important driver of the global market for fish oil. Nutrition & Supplement Companies in focus today are: Axxess Pharma Inc. (OTC: AXXE), MusclePharm Corporation (OTC: MSLP), GNC Holdings, Inc. (NYSE: GNC), Herbalife Ltd. (NYSE: HLF) and Amarin Corporation Plc (NASDAQ: AMRN).
HLF: 43.83 (-0.86), AMRN: 2.59 (unch), GNC: 47.51 (+0.72)

MusclePharm Launches New Product Line: Hardcore Series #HARDCOREMINDSET
Marketwired - Mon Mar 16, 7:01AM CDT
MusclePharm Corporation (OTCQB: MSLP), a scientifically driven, performance-lifestyle sports nutrition company, today launched an exclusive brand for Bodybuilding.com: The MusclePharm Hardcore Series -- a series of products designed for the high-performing athlete with no propriety blends.

Next Week In Biotech: Vertex PDUFA, Organon Ad Comm
SA Editor Mike Taylor - Seeking Alpha - Fri Mar 13, 8:00AM CDT
Every Friday morning, Seeking Alpha posts a calendar of the next week's expected biotech events to start a forward-looking conversation. Please be aware that dates and events can be subject to change. Please let us know in a comment or message if you...
BDSI: 9.50 (+0.02), VRTX: 128.47 (+2.83), CERU: 6.59 (+0.20), FOMX: 9.87 (+0.45), ONTX: 2.39 (+0.06), PFNX: 18.98 (+2.17), OMER: 24.58 (+0.44), PGNX: 5.97 (+0.09), SYN: 2.12 (+0.01), VCYT: 8.16 (-0.08), STEM: 1.00 (-0.01), APRI: 1.79 (-0.02), KPTI: 32.08 (+0.67)

Coalition of state attorneys general to probe herbal supplement makers
Seeking Alpha - at Seeking Alpha - Tue Mar 10, 9:53AM CDT

HLF: 43.83 (-0.86), VSI: 40.55 (-0.01), GNC: 47.51 (+0.72)

MusclePharm Schedules 2014 Fourth Quarter and Full Year Financial Results Press Release and Conference Call
Marketwired - Tue Mar 10, 6:30AM CDT
MusclePharm Corporation (OTCQB: MSLP), a scientifically-driven, performance-lifestyle sports nutrition company, will report its financial results for the fourth quarter and year ended December 31, 2014 on Monday, March 16, 2015, following market close.

New finance chief at MusclePharm
Seeking Alpha - at Seeking Alpha - Fri Mar 06, 7:11AM CST


MusclePharm inks manufacturing deal with nutrition products maker
Seeking Alpha - at Seeking Alpha - Wed Mar 04, 7:54AM CST


MusclePharm Names Brian Cavanaugh as Senior VP of Retail & Brand Strategy
Marketwired - Tue Mar 03, 7:01AM CST
MusclePharm Corporation (OTCQB: MSLP), a scientifically driven, performance-lifestyle sports nutrition company, today announced that Brian Cavanaugh has joined the company as Senior Vice President of Retail and Brand Strategy. In this new capacity, Cavanaugh will oversee MusclePharm's growing brand portfolio in a variety of areas including new product development and strategy, brand positioning, and support with overall company retail marketing strategy.

I Made An Error In Switching To FitLife
Paulo Santos - at Seeking Alpha - Wed Feb 11, 8:45AM CST


Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 31

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Bank of Canada Considers Interest Rate Cuts Amid Growth Concerns

Updated Category News Views 91

Bank of Canada Considers Possible Rate Cuts Recent discussions reported by the Financial Times reveal that Governor Tiff Macklem of the Bank of Canada has started exploring the possibility of increasing the pace at which interest rates could be cut. This potential shift highlights the Bank's response to growing concerns about the Canadian economy's current dynamics....

Continue Reading
Photonics Market Poised for Massive Growth by 2030

Updated Category News Views 151

Understanding the Photonics Market Growth The photonics industry is on an impressive trajectory, with projections indicating it will grow significantly over the coming years. Experts foresee the market expanding from approximately USD 1,093.96 billion to an astounding USD 1,481.80 billion by 2030, reflecting a compound annual growth rate (CAGR) of around 6.3%. This rapid...

Continue Reading
Brookfield Infrastructure Plans Redemption of Preferred Units

Updated Category News Views 154

Brookfield Infrastructure Announces Series 3 Redemption Plan BROOKFIELD, News - Brookfield Infrastructure Partners L.P. (TSX: BIP.UN; NYSE: BIP) has announced its intention to redeem all outstanding Cumulative Class A Preferred Limited Partnership Units, Series 3 (the “Series 3 Preferred Units”). This strategic decision aims to enhance their portfolio's financial...

Continue Reading
How a $1000 Investment in Enphase Energy Grew to $3200

Updated Category News Views 147

Transforming $1000 into $3200 with Enphase Energy Investing can be a journey filled with uncertainties, but the story of Enphase Energy (NASDAQ: ENPH) reveals a powerful lesson in the potential of financial growth. Over the past five years, Enphase Energy has impressively outperformed many market benchmarks, achieving a remarkable annualized return of 26.49%. At present,...

Continue Reading
Investors Should Pay Attention: Rocket Pharmaceuticals Lawsuit Update

Updated Category News Views 191

The Class Action Lawsuit Against Rocket Pharmaceuticals Recently, investors of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) have been advised to participate in a class action lawsuit for potential securities fraud. This lawsuit arises from significant concerns over the company's disclosure practices and the impact of leadership decisions on stock performance. If you are an...

Continue Reading